» Articles » PMID: 38882010

Efficacy of Rapid Antigen Self-testing for SARS-CoV-2 Screening: Real-world Evidence from a Prospective Cohort Study

Overview
Journal Genes Dis
Date 2024 Jun 17
PMID 38882010
Authors
Affiliations
Soon will be listed here.
References
1.
Larremore D, Wilder B, Lester E, Shehata S, Burke J, Hay J . Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening. Sci Adv. 2020; 7(1). PMC: 7775777. DOI: 10.1126/sciadv.abd5393. View

2.
Garcia-Finana M, Hughes D, Cheyne C, Burnside G, Stockbridge M, Fowler T . Performance of the Innova SARS-CoV-2 antigen rapid lateral flow test in the Liverpool asymptomatic testing pilot: population based cohort study. BMJ. 2021; 374:n1637. PMC: 8259455. DOI: 10.1136/bmj.n1637. View

3.
Drain P . Rapid Diagnostic Testing for SARS-CoV-2. N Engl J Med. 2022; 386(3):264-272. PMC: 8820190. DOI: 10.1056/NEJMcp2117115. View

4.
Zhang X, Barr B, Green M, Hughes D, Ashton M, Charalampopoulos D . Impact of community asymptomatic rapid antigen testing on covid-19 related hospital admissions: synthetic control study. BMJ. 2022; 379:e071374. PMC: 9682337. DOI: 10.1136/bmj-2022-071374. View